ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 39 filers reported holding ANNOVIS BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,209 | -33.6% | 34,374 | 0.0% | 0.11% | -29.6% |
| Q2 2023 | $491,204 | -4.5% | 34,374 | +3.0% | 0.16% | -6.4% |
| Q1 2023 | $514,293 | +17.9% | 33,374 | +2.8% | 0.17% | +10.9% |
| Q4 2022 | $436,126 | -2.0% | 32,474 | 0.0% | 0.16% | -6.6% |
| Q3 2022 | $445,000 | +45.4% | 32,474 | +20.4% | 0.17% | +59.0% |
| Q2 2022 | $306,000 | +20.9% | 26,974 | +42.2% | 0.10% | +45.8% |
| Q1 2022 | $253,000 | -0.4% | 18,974 | +31.1% | 0.07% | 0.0% |
| Q4 2021 | $254,000 | -44.8% | 14,474 | 0.0% | 0.07% | -47.4% |
| Q3 2021 | $460,000 | -73.9% | 14,474 | -29.6% | 0.14% | -73.4% |
| Q2 2021 | $1,761,000 | +99.2% | 20,574 | -35.1% | 0.52% | +80.7% |
| Q1 2021 | $884,000 | +132.0% | 31,678 | -37.4% | 0.28% | +120.9% |
| Q4 2020 | $381,000 | +55.5% | 50,588 | -0.9% | 0.13% | +37.2% |
| Q3 2020 | $245,000 | – | 51,038 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 48,941 | $464,450 | 0.22% |
| Redmond Asset Management, LLC | 34,080 | $323,419 | 0.12% |
| Sterling Investment Advisors, Ltd. | 34,374 | $326,209 | 0.11% |
| Wescott Financial Advisory Group, LLC | 41,607 | $394,850 | 0.07% |
| Worth Venture Partners, LLC | 12,321 | $116,926 | 0.07% |
| Koshinski Asset Management, Inc. | 15,000 | $142,350 | 0.02% |
| Merit Financial Group, LLC | 41,200 | $390,988 | 0.01% |
| FNY Investment Advisers, LLC | 1,133 | $10 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | $2,847,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $223,964 | 0.01% |